Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
Malaria remains a major infectious disease and, despite incidence reduction, it threatens resurgence in drug-resistant forms. Antimalarial drugs remain the mainstay of therapeutic options and hence there is a constant need to identify and validate new druggable targets. Plasmodium falciparum aminoac...
Egile Nagusiak: | Manickam, Y, Chaturvedi, R, Babbar, P, Malhotra, N, Jain, V, Sharma, A |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Elsevier
2018
|
Antzeko izenburuak
-
Growth-Optimized Aminoacyl-tRNA Synthetase Levels Prevent Maximal tRNA Charging
nork: Parker, Darren J., et al.
Argitaratua: (2021) -
Functional analysis of a class II aminoacyl-tRNA synthetase
nork: Davis, Matthew W. (Matthew Warren), 1966-
Argitaratua: (2005) -
Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo
nork: Camacho, Noelia, et al.
Argitaratua: (2015) -
Characterizing the landscape of aminoacyl-tRNA synthetase protein production in Bacillus subtilis
nork: Parker, Darren John.
Argitaratua: (2021) -
Molecular Evolution of Aminoacyl tRNA Synthetase Proteins in the Early History of Life
nork: Fournier, Gregory P., et al.
Argitaratua: (2013)